PODD
Insulet Corp. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers):
breedte van houders +4.3% ·
aandelenstroom -1.5% ·
netto nieuwe posities 0.0%
· formule
Fragmentatie van eigendom: meer houders, kleiner totaalbelang
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | 0 | 52.88M | $8.06B | +7 | −8 |
| Q1 2026 | 162 | -3 | 53.76M | $11.28B | +2 | −6 |
| Q4 2025 | 164 | +1 | 61.46M | $17.44B | +2 | n/a |
| Q3 2025 | 24 | +1 | 35.22M | $10.87B | +1 | −1 |
| Q2 2025 | 21 | -2 | 34.19M | $10.74B | n/a | −2 |
| Q1 2025 | 20 | +1 | 10.99M | $2.88B | +1 | n/a |
| Q4 2024 | 19 | 0 | 11.49M | $3.00B | +1 | −1 |
| Q3 2024 | 18 | 0 | 8.60M | $2.00B | +1 | −1 |
| Q2 2024 | 18 | n/a | 10.07M | $2.03B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 8.80M | +1.0% | $2.72B | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | Fidelity (FMR) ✦ | 7.57M | +0.8% | $2.34B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 3 | BlackRock ✦ (passief) | 6.59M | +2.8% | $2.04B | 0.0% | ▲ Add | 2 | SEC ↗ ×21 |
| 4 | State Street Global Advisors ✦ (passief) | 3.09M | +1.1% | $954.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 2.09M | -2.0% | $645.77M | 0.5% | ▼ Trim | 6 | SEC ↗ ×4 |
| 6 | Geode Capital Management ✦ (passief) | 1.97M | +2.0% | $604.49M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 1.27M | n/a | $391.81M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 8 | Goldman Sachs Group ✦ | 757.81K | n/a | $233.96M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 9 | JPMorgan Chase ✦ | 556.53K | n/a | $171.82M | 0.0% | n/c | 1 | SEC ↗ ×34 |
| 10 | Renaissance Technologies ✦ | 390.89K | +4.5% | $120.68M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 352.44K | -54.3% | $108.81M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | Marshall Wace ✦ | 280.47K | -55.4% | $86.59M | 0.1% | ▼ Trim | 6 | SEC ↗ ×3 |
| 13 | Two Sigma Investments ✦ | 250.80K | -31.0% | $77.43M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 235.60K | +5.2% | $72.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Millennium Management ✦ | 200.87K | -14.4% | $62.01M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | Wellington Management ✦ | 189.52K | -33.0% | $58.51M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 17 | AQR Capital Management ✦ | 175.47K | +63.1% | $53.92M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 18 | Capital World Investors ✦ | 168.00K | 0.0% | $51.87M | 0.0% | Held | 6 | SEC ↗ |
| 19 | PRIMECAP Management ✦ | 124.11K | -34.2% | $38.32M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 66.37K | +147.9% | $20.49M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 46.27K | +38.0% | $14.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 21.09K | +816.7% | $6.51M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 15.64K | +195.8% | $4.83M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 14.10K | Nieuw | $4.35M | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Adage Capital Partners | $4.35M | 0.0% |
Verlaten
| Norges Bank | $324.69M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 779 houders, 69.27M aandelen, $13.82B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · President and CEO · 1.10K aand @ 147.47 · $162,217
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie